Compounds > n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea
Page last updated: 2024-09-03

n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea and Local Neoplasm Recurrence

n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea has been researched along with Local Neoplasm Recurrence in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bay, JO; Chazal, J; Chollet, P; Curé, H; Durando, X; Lemaire, JJ; Lentz, MA; Roché, H; Thivat, E; Verrelle, P1
Adenis, A; Chollet, P; Cure, H; Fargeot, P; Fumoleau, P; Hanausk, A; Lentz, MA; Madelmont, JC; Roche, H; Terret, C1

Trials

2 trial(s) available for n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea and Local Neoplasm Recurrence

ArticleYear
Cystemustine in recurrent high grade glioma.
    Journal of neuro-oncology, 2006, Volume: 79, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Brain Neoplasms; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Prognosis; Survival Analysis; Survival Rate; Treatment Outcome

2006
Phase II trial of cystemustine, a new nitrosourea, as treatment of high-grade brain tumors in adults.
    Journal of neuro-oncology, 2000, Volume: 49, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Brain Neoplasms; Female; Glioblastoma; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Nitrosourea Compounds; Thrombocytopenia; Tomography, X-Ray Computed

2000